Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Ketamine + remifentanil versus ketamine + propofol for closed nasal bone reduction
IRCT20181127041768N1Phase 3Completed
- Sponsor
- Kurdistan University of Medical Sciences
- Start
- Aug 2018
- Modality
- Small Molecules, Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, single-blind trial comparing Ketamine + remifentanil with Ketamine + propofol (2 arms). Primary endpoints: pain, agitation and 1 more. Started Aug 2018; status: completed.
02
Drugs
ketamineremifentanilpropofol
Beyond the preview
Go deeper on IRCT20181127041768N1.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT20181127041768N1.